BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1065@pharmaconomics
DTSTAMP:20260707T034539Z
DTSTART;VALUE=DATE:20260514
DTEND;VALUE=DATE:20260515
SUMMARY:INMB PDUFA — XPro1595
DESCRIPTION:The FDA's approval decision on XPro1595 for Alzheimer's disease is due May 14\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1711754/000121390026064144/ea029332501ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/1065
URL:https://www.pharmaconomics.com/e/1065
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:INMB catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR